Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Bone health
•
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
•
Geriatric Medicine
•
General Geriatric Medicine
•
General Primary Care
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
Related Questions
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
How do you approach decision-making around initiation of osteoporosis therapy in patients with advanced dementia?
Would you start romosozumab in an active smoker?
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
What is your clinical approach to deprescribing vs continuing low-dose aspirin used for primary prevention in older adults who are already taking this medication?
What practical next steps would you recommend once identifying loneliness in an older adult patient?
In adults ≥80 years with TSH 6–10 mIU/L and minimal symptoms, do you initiate levothyroxine, monitor, or avoid treatment entirely?
Do you have any pearls for how to manage OSA with CPAP in older adults with cognitive impairment?
